Low-normal or excessive body mass index: Newly identified and powerful risk factors for death and other complications with percutaneous coronary intervention

被引:118
作者
Ellis, SG
Elliott, J
Horrigan, M
Raymond, RE
Howell, G
机构
[1] Cleveland Clinic Foundation, Cleveland, OH
[2] Cleveland Clinic Foundation, Cleveland, OH 44195, 9500 Euclid Ave.
关键词
D O I
10.1016/S0002-9149(96)00386-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recognized risk factors account for only a small portion of the variance in the 4% to 10% incidence of major ischemic events associated with percutaneous coronary intervention. Body mass index (BMI) (body weight in kg/[height in m](2)) is a clinically useful estimate of body fat and has been shown to correlate with mortality from several causes, We sought to evaluate the effect of BMI as a potential risk factor for the complications of percutaneous coronary intervention in 3,571 consecutive percutaneous coronary intervention patients treated at a single referral center. Patients were prospectively divided into the nonobese (BMI less than or equal to 25), mildly obese (BMI 26-35), and very obese (BMI >35), based on accepted definitions. Multiple logistic regression analyses were used to determine the correlates of major complications from 25 candidate variables, including BMI less than or equal to 25 (n = 614 patients) and BMI >35 (n = 275 patients), recorded prospectively in a relational database. Death occurred in 2.8% of the BMI less than or equal to 25 group, in 3.7% of the BMI >35 group, and in 0.9% of the BMI 26-34 group (p <0.001), but there was no difference in the incidence of other ischemic events. Blood product transfusion was required in 12% of the BMI less than or equal to 25 group, in 7% of the BMI 25-34 group, and in 8% of the BMI >35% group (p = 0.003). Multivariate analysis, after adjustment for other significant correlates, demonstrated that both BMI less than or equal to 25 (odds ratio [OR] = 2.7, p = 0.005) and BMI >35 (OR = 7.4, p <0.001) were independent correlates of death. Low-normal or high BMI is a newly described and powerful risk factor for in-hospital death after percutaneous coronary intervention.
引用
收藏
页码:642 / 646
页数:5
相关论文
共 17 条
  • [1] OBESITY AND CARDIAC-FUNCTION
    DEDIVITIIS, O
    FAZIO, S
    PETITTO, M
    MADDALENA, G
    CONTALDO, F
    MANCINI, M
    [J]. CIRCULATION, 1981, 64 (03) : 477 - 482
  • [2] ENERGY REQUIREMENT FOR DEFIBRILLATION OF A MARKEDLY OVERWEIGHT PATIENT
    DESILVA, RA
    LOWN, B
    [J]. CIRCULATION, 1978, 57 (04) : 827 - 830
  • [3] INCIDENCE AND CONSEQUENCES OF PERIPROCEDURAL OCCLUSION - THE 1985-1986 NATIONAL HEART, LUNG, AND BLOOD INSTITUTE PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY REGISTRY
    DETRE, KM
    HOLMES, DR
    HOLUBKOV, R
    COWLEY, MJ
    BOURASSA, MG
    FAXON, DP
    DORROS, GR
    BENTIVOGLIO, LG
    KENT, KM
    MYLER, RK
    [J]. CIRCULATION, 1990, 82 (03) : 739 - 750
  • [4] Analysis and comparison of operator-specific outcomes in interventional cardiology - From a multicenter database of 4860 quality-controlled procedures
    Ellis, SG
    Omoigui, N
    Bittl, JA
    Lincoff, M
    Wolfe, MW
    Howell, G
    Topol, EJ
    [J]. CIRCULATION, 1996, 93 (03) : 431 - 439
  • [5] CORONARY MORPHOLOGICAL AND CLINICAL DETERMINANTS OF PROCEDURAL OUTCOME WITH ANGIOPLASTY FOR MULTIVESSEL CORONARY-DISEASE - IMPLICATIONS FOR PATIENT SELECTION
    ELLIS, SG
    VANDORMAEL, MG
    COWLEY, MJ
    DISCIASCIO, G
    DELIGONUL, U
    TOPOL, EJ
    BULLE, TM
    [J]. CIRCULATION, 1990, 82 (04) : 1193 - 1202
  • [6] CAUSES AND CORRELATES OF DEATH AFTER UNSUPPORTED CORONARY ANGIOPLASTY - IMPLICATIONS FOR USE OF ANGIOPLASTY AND ADVANCED SUPPORT TECHNIQUES IN HIGH-RISK SETTINGS
    ELLIS, SG
    MYLER, RK
    KING, SB
    DOUGLAS, JS
    TOPOL, EJ
    SHAW, RE
    STERTZER, SH
    ROUBIN, GS
    MURPHY, MC
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (15) : 1447 - 1451
  • [7] COMPARISON OF COMPLICATIONS DURING PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY FROM 1977 TO 1981 AND FROM 1985 TO 1986 - THE NATIONAL-HEART-LUNG-AND-BLOOD-INSTITUTE PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY REGISTRY
    HOLMES, DR
    HOLUBKOV, R
    VLIETSTRA, RE
    KELSEY, SF
    REEDER, GS
    DORROS, G
    WILLIAMS, DO
    COWLEY, MJ
    FAXON, DP
    KENT, KM
    BENTIVOGLIO, LG
    DETRE, K
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1988, 12 (05) : 1149 - 1155
  • [8] INCREASED PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 LEVELS - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND ATHEROTHROMBOSIS
    JUHANVAGUE, I
    ALESSI, MC
    VAGUE, P
    [J]. DIABETOLOGIA, 1991, 34 (07) : 457 - 462
  • [9] ABRUPT VESSEL CLOSURE COMPLICATING CORONARY ANGIOPLASTY - CLINICAL, ANGIOGRAPHIC AND THERAPEUTIC PROFILE
    LINCOFE, AM
    POPMA, JJ
    ELLIS, SG
    HACKER, JA
    TOPOL, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 19 (05) : 926 - 935
  • [10] BODY-WEIGHT AND LONGEVITY - A REASSESSMENT
    MANSON, JE
    STAMPFER, MJ
    HENNEKENS, CH
    WILLETT, WC
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 257 (03): : 353 - 358